Over the past 12 months, 3 insiders at Nuvation Bio Inc. filed 10 open-market SEC Form 4 transactions on NUVB: 0 purchases worth $0 and 10 sales worth $6.2M. Insiders have been net sellers over this period. The most recent filing was on Dec 1, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 1, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 150.0K | $7.82 | $1.2M |
| Nov 26, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 10.0K | $8.00 | $80K |
| Nov 25, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 10.0K | $7.50 | $75K |
| Nov 20, 25 | Gary HattersleyCHIEF SCIENTIFIC OFFICER | SELL | 300.0K | $7.23 | $2.2M |
| Nov 20, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 20.0K | $7.00 | $140K |
| Nov 19, 25 | David C. HanleyCHIEF TECHNICAL OPERATIONS | SELL | 200.0K | $7.14 | $1.4M |
| Nov 19, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 15.0K | $5.10 | $77K |
| Nov 17, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 15.0K | $4.77 | $72K |
| Oct 27, 25 | Gary HattersleyCHIEF SCIENTIFIC OFFICER | SELL | 100.0K | $5.02 | $502K |
| Jun 18, 25 | Stacy MarkelCHIEF PEOPLE OFFICER | BUY | 10.0K | $1.71 | $17K |
| Jun 17, 25 | Philippe SauvageChief Financial Officer | BUY | 4.0K | $1.79 | $7K |
| Jun 16, 25 | David HungPRESIDENT AND CEO | BUY | 500.0K | $1.79 | $895K |
| Jun 16, 25 | Philippe SauvageChief Financial Officer | BUY | 3.3K | $1.84 | $6K |
| Jun 16, 25 | Colleen SjogrenChief Commercial Officer | BUY | 50.0K | $1.81 | $91K |
| Jun 16, 25 | Kerry WentworthCHIEF REGULATORY OFFICER | BUY | 26.0K | $1.80 | $47K |
| May 2, 25 | Dongfang LiuCHIEF MEDICAL OFFICER | SELL | 20.0K | $2.50 | $50K |
| Apr 7, 25 | David HungPRESIDENT AND CEO | BUY | 300.0K | $1.63 | $489K |
| Apr 4, 25 | David HungPRESIDENT AND CEO | BUY | 200.0K | $1.66 | $332K |
| Apr 1, 25 | Robert MashalDirector | BUY | 98.9K | $1.67 | $165K |
| Nov 11, 24 | Junyuan Jerry WangCEO, ANHEART THERAPEUTICS LTD. | SELL | 56.4K | $2.89 | $163K |
| Oct 8, 24 | Robert MashalDirector | BUY | 100.0K | $2.20 | $220K |
| Jun 25, 24 | Xiangmin CuiDirector | BUY | 277.9K | $2.97 | $825K |
| Jun 24, 24 | Xiangmin CuiDirector | BUY | 336.9K | $2.98 | $1.0M |
| Jun 21, 24 | Xiangmin CuiDirector | BUY | 75.4K | $3.00 | $226K |
| Jun 20, 24 | Xiangmin CuiDirector | BUY | 87.7K | $2.99 | $262K |
| Jun 11, 24 | Kim D BlickenstaffDirector | BUY | 172.2K | $2.90 | $499K |
| Sep 21, 23 | Ecor1 Capital Fund Qualified, L.p.Director | BUY | 53.0K | $1.36 | $72K |
| Sep 20, 23 | Ecor1 Capital Fund Qualified, L.p.Director | BUY | 117.1K | $1.36 | $159K |
| Sep 19, 23 | Ecor1 Capital Fund Qualified, L.p.Director | BUY | 5.14M | $1.26 | $6.5M |
| Feb 21, 23 | Oleg NodelmanDirector | BUY | 53.0K | $1.36 | $72K |
| Feb 20, 23 | Oleg NodelmanDirector | BUY | 117.1K | $1.36 | $159K |
| Feb 19, 23 | Oleg NodelmanDirector | BUY | 5.14M | $1.26 | $6.5M |
| Dec 5, 22 | Kathryn E FalbergDirector | BUY | 43.0K | $1.95 | $84K |
| Dec 2, 22 | Kathryn E FalbergDirector | BUY | 47.0K | $1.98 | $93K |
| Dec 1, 22 | Kathryn E FalbergDirector | BUY | 85.0K | $1.97 | $167K |
| Nov 30, 22 | Kathryn E FalbergDirector | BUY | 75.0K | $1.85 | $139K |
| Apr 5, 22 | Omega Fund V Gp Manager, Ltd.TenPercentOwner | SELL | 2.50M | $5.60 | $14.0M |
| Dec 15, 21 | Omega Fund IV Gp, L.p.TenPercentOwner | SELL | 500.0K | $10.07 | $5.0M |
| Dec 7, 21 | Omega Fund V, L.p.TenPercentOwner | SELL | 1.40M | $9.80 | $13.7M |
| Nov 24, 21 | Ecor1 Capital, LlcOther | BUY | 163.3K | $7.69 | $1.3M |
| Nov 23, 21 | Omega Fund V Gp Manager, Ltd.TenPercentOwner | SELL | 36 | $9.75 | $351 |
| Nov 22, 21 | Omega Fund V Gp Manager, Ltd.TenPercentOwner | SELL | 295.0K | $9.76 | $2.9M |
| Nov 3, 21 | Omega Fund V Gp, L.p.TenPercentOwner | SELL | 2.00M | $9.25 | $18.5M |
| Oct 29, 21 | Omega Fund V Gp Manager, Ltd.TenPercentOwner | SELL | 45.0K | $9.27 | $417K |
| Oct 28, 21 | Omega Fund V Gp Manager, Ltd.TenPercentOwner | SELL | 1.01M | $9.60 | $9.7M |
| Jul 31, 21 | Ecor1 Capital, LlcOther | BUY | 56.6K | $8.64 | $489K |
| Jul 31, 21 | Ecor1 Capital, LlcOther | SELL | 56.6K | $8.64 | $489K |
Over the past 12 months, insiders at Nuvation Bio Inc. filed 0 open-market purchases worth $0 and 10 sales worth $6.2M on NUVB, which makes them net sellers over the period. The most recent Form 4 was filed on Dec 1, 25.
The largest recent open-market NUVB insider purchase in our data was $6.5M by Ecor1 Capital Fund Qualified, L.p., Director, filed on Sep 19, 23.
3 different insiders at Nuvation Bio Inc. filed open-market SEC Form 4 transactions on NUVB over the last 12 months.
InsiderTape plots every NUVB insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Nuvation Bio Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →